Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 21, 2016; 22(43): 9586-9594
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9586
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9586
Figure 2 Receiver operating characteristic curves of six non-invasive models - FIB-4, APPCI, GP, APRI, CG, and PPT - and models to predict significant fibrosis in the whole cohort.
- Citation: Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World J Gastroenterol 2016; 22(43): 9586-9594
- URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9586.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i43.9586